An experimental treatment has been shown to significantly reduce "bad" cholesterol, with some reports suggesting it may be as effective as injectables. The treatment, which involves gene editing, has been tested in a first-in-human trial and has been found to safely lower cholesterol and triglycerides. The duration of the treatment's effects is unclear, with some reports indicating it may provide long-term or even lifetime control of cholesterol levels.